US court : Teva loses Copaxone patent suit

– The Southern District of New York dismissed Teva’s lawsuit against Mylan for the infringement of patents on its MS treatment. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) More...